These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3147701)

  • 1. Mechanisms of pathogenicity in mycobacteria.
    Rastogi N; David HL
    Biochimie; 1988 Aug; 70(8):1101-20. PubMed ID: 3147701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Specific lipids of mycobacteria].
    Asselineau C; Asselineau J
    Ann Microbiol (Paris); 1978 Jan; 129(1):49-69. PubMed ID: 655525
    [No Abstract]   [Full Text] [Related]  

  • 3. Lipids of pathogenic Mycobacteria: contributions to virulence and host immune suppression.
    Guenin-Macé L; Siméone R; Demangel C
    Transbound Emerg Dis; 2009 Aug; 56(6-7):255-68. PubMed ID: 19486312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Slow growth rate of mycobacteria. Possible reasons and significance for their pathogenicity].
    Lewin A; Sharbati-Tehrani S
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Dec; 48(12):1390-9. PubMed ID: 16283122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mycobacteria: an introduction to nomenclature and pathogenesis.
    Rastogi N; Legrand E; Sola C
    Rev Sci Tech; 2001 Apr; 20(1):21-54. PubMed ID: 11288513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Molecular pathogenesis of mycobacterial diseases].
    Kobayashi K
    Nihon Hansenbyo Gakkai Zasshi; 2004 Sep; 73(3):263-70. PubMed ID: 15508729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Phagocytosis and the antiphagocytic factors in mycobacterial infections].
    Pinchuk LM
    Mikrobiol Zh (1978); 1992; 54(2):93-105. PubMed ID: 1584091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on lipids in mycobacterial cell wall: their important structure and function relating to pathogenicity and their biological activity.
    Bera A; Banerjee A
    Indian J Lepr; 1989 Apr; 61(2):143-50. PubMed ID: 2664014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of mycobacterial glycolipids with host cells.
    Vergne I; Daffé M
    Front Biosci; 1998 Aug; 3():d865-76. PubMed ID: 9693156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Biochemistry and bioactivities of mycobacterial components].
    Yano I
    Nihon Rinsho; 1998 Dec; 56(12):3008-16. PubMed ID: 9883601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathogenicity of atypical mycobacteria].
    Frati Munari C
    Prensa Med Mex; 1977; 42(3-4):113-9. PubMed ID: 162750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How to establish a lasting relationship with your host: lessons learned from Mycobacterium spp.
    Rhoades ER; Ullrich HJ
    Immunol Cell Biol; 2000 Aug; 78(4):301-10. PubMed ID: 10947853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The many niches and strategies used by pathogenic mycobacteria for survival within host macrophages.
    de Chastellier C
    Immunobiology; 2009; 214(7):526-42. PubMed ID: 19261352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of persistence of mycobacteria.
    Britton WJ; Roche PW; Winter N
    Trends Microbiol; 1994 Aug; 2(8):284-8. PubMed ID: 7981971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of host- and pathogen-associated lipids in directing the immune response in mycobacterial infections, with emphasis on Mycobacterium avium subsp. paratuberculosis.
    Thirunavukkarasu S; de Silva K; Plain KM; J Whittington R
    Crit Rev Microbiol; 2016; 42(2):262-75. PubMed ID: 25163812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycobacteria glycolipids as potential pathogenicity effectors: alteration of model and natural membranes.
    Sut A; Sirugue S; Sixou S; Lakhdar-Ghazal F; Tocanne JF; Lanéelle G
    Biochemistry; 1990 Sep; 29(36):8498-502. PubMed ID: 2123718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Playing hide-and-seek with host macrophages through the use of mycobacterial cell envelope phthiocerol dimycocerosates and phenolic glycolipids.
    Arbues A; Lugo-Villarino G; Neyrolles O; Guilhot C; Astarie-Dequeker C
    Front Cell Infect Microbiol; 2014; 4():173. PubMed ID: 25538905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The secret lives of the pathogenic mycobacteria.
    Cosma CL; Sherman DR; Ramakrishnan L
    Annu Rev Microbiol; 2003; 57():641-76. PubMed ID: 14527294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenic and immunosuppressive properties of mycobacterial phenolic glycolipids.
    Oldenburg R; Demangel C
    Biochimie; 2017 Oct; 141():3-8. PubMed ID: 28322927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The envelope layers of mycobacteria with reference to their pathogenicity.
    Daffé M; Draper P
    Adv Microb Physiol; 1998; 39():131-203. PubMed ID: 9328647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.